Open AccessPercutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma
Author(s) -
Edward Leen,
John Picard,
Justin Stebbing,
Mark Abel,
Tony Dhillon,
Harpreet Wasan
Publication year - 2018
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2018.01.14
Subject(s) - medicine , irreversible electroporation , percutaneous , electroporation , adenocarcinoma , cancer , biochemistry , chemistry , gene
The prognosis for unresectable locally advanced pancreatic adenocarcinoma (LAPC) remains poor. There is increasing interest in modern ablative techniques to improve outcomes. We report on the potential value of integrating percutaneous irreversible electroporation (IRE) in patients undergoing systemic chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom